Crossmark

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site

Crossref DOI link: https://doi.org/10.1186/s12885-018-4092-4

Published Online: 2018-02-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kodaira, Makoto http://orcid.org/0000-0002-1977-0350
Yonemori, Kan

Shimoi, Tatsunori

Yoshida, Akihiko

Yoshida, Masayuki

Kitano, Atsuko

Shimomura, Akihiko

Yunokawa, Mayu

Shimizu, Chikako

Takiguchi, Yuichi

Fujiwara, Yasuhiro

Tamura, Kenji
More Information

Article History

Received: 10 November 2016

Accepted: 5 February 2018

First Online: 13 February 2018

Ethics approval and consent to participate

: This study was approved by the National Cancer Center Institutional Review Board (No. 2012–335). Written informed consent was not obtained because of the retrospective nature of this study. This study was publicized via the web page of the hospital.

: Not applicable.

: The authors have no conflict of interest directly relevant to the content of this article.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.